Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes

This study examines whether semaglutide — a medication commonly used for type 2 diabetes and weight loss — can benefit younger adults with type 1 diabetes by improving heart health and kidney function. Because type 1 diabetes significantly increases the risk of heart and kidney disease, researchers want to see if semaglutide offers similar protective benefits as it does in type 2 diabetes. **You may be eligible if...** - You are between 18 and 49 years old - You have type 1 diabetes - You use an insulin pump or automated insulin delivery system - Your kidney function is acceptable (eGFR ≥ 45) - Your BMI is between 20 and 45 **You may NOT be eligible if...** - You have had a serious low blood sugar episode requiring help from another person in the past 6 months - You have a history of pancreatitis or thyroid cancer - You have very poor kidney function - You are pregnant or planning to become pregnant Talk to your doctor to see if this trial is right for you.